A detailed history of Citigroup Inc transactions in Envista Holdings Corp stock. As of the latest transaction made, Citigroup Inc holds 89,324 shares of NVST stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,324
Previous 78,263 14.13%
Holding current value
$1.91 Million
Previous $1.67 Million 11.24%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$16.0 - $21.1 $176,976 - $233,387
11,061 Added 14.13%
89,324 $1.49 Million
Q1 2024

May 10, 2024

SELL
$20.64 - $25.45 $355,544 - $438,401
-17,226 Reduced 18.04%
78,263 $1.67 Million
Q4 2023

Feb 09, 2024

BUY
$21.06 - $27.57 $967,875 - $1.27 Million
45,958 Added 92.79%
95,489 $2.3 Million
Q3 2023

Nov 09, 2023

BUY
$27.56 - $35.7 $386,143 - $500,192
14,011 Added 39.45%
49,531 $1.38 Million
Q2 2023

Aug 10, 2023

SELL
$31.53 - $39.74 $8.7 Million - $11 Million
-276,052 Reduced 88.6%
35,520 $1.2 Million
Q1 2023

May 11, 2023

BUY
$32.84 - $42.5 $8.45 Million - $10.9 Million
257,283 Added 473.91%
311,572 $12.7 Million
Q4 2022

Feb 09, 2023

SELL
$32.54 - $37.99 $638,304 - $745,211
-19,616 Reduced 26.54%
54,289 $1.83 Million
Q3 2022

Nov 10, 2022

SELL
$32.81 - $41.51 $37.5 Million - $47.5 Million
-1,144,438 Reduced 93.93%
73,905 $2.43 Million
Q2 2022

Aug 10, 2022

BUY
$35.59 - $48.1 $41.6 Million - $56.2 Million
1,168,465 Added 2342.65%
1,218,343 $47 Million
Q1 2022

May 12, 2022

SELL
$41.4 - $50.9 $613,837 - $754,694
-14,827 Reduced 22.91%
49,878 $2.43 Million
Q4 2021

Feb 10, 2022

BUY
$37.73 - $46.74 $401,447 - $497,313
10,640 Added 19.68%
64,705 $2.92 Million
Q3 2021

Nov 10, 2021

BUY
$39.75 - $44.09 $2.15 Million - $2.38 Million
54,065 New
54,065 $2.26 Million

Others Institutions Holding NVST

About Envista Holdings Corp


  • Ticker NVST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 163,391,008
  • Market Cap $3.5B
  • Description
  • Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...
More about NVST
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.